UTAH MEDICAL PRODUCTS, INC. (UTMD) Net margin 2016–2025
UTAH MEDICAL PRODUCTS, INC. (UTMD) net profit margin by fiscal year — reported net income divided by reported revenue.
29.3%FY2025 · since FY2016: 30.9% → 29.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 29.3% | -4.6 pp |
| FY2024 | 33.9% | +0.8 pp |
| FY2023 | 33.1% | +1.6 pp |
| FY2022 | 31.5% | +1.4 pp |
| FY2021 | 30.1% | +4.5 pp |
| FY2020 | 25.6% | -5.8 pp |
| FY2019 | 31.4% | -12.8 pp |
| FY2018 | 44.2% | +23.6 pp |
| FY2017 | 20.5% | -10.3 pp |
| FY2016 | 30.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More UTMD financial trends
UTMD RevenueUTMD Net incomeUTMD Gross profitUTMD Gross marginUTMD Operating incomeUTMD Operating marginUTMD Operating cash flowUTMD Free cash flowUTMD Capital expendituresUTMD Return on equityUTMD Stock buybacksUTMD Dividends paidUTMD Total assetsUTMD Total liabilitiesUTMD Shareholders’ equityUTMD overview →